XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid‑In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   119,426,064      
Beginning balance at Dec. 31, 2021 $ 738,426 $ 119 $ 913,581 $ (7,866) $ (167,408)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   747,410      
Exercise of stock options 4,682 $ 1 4,681    
Vesting of restricted stock units (in shares)   1,036,161      
Issuance of common stock under the employee stock purchase plan (in shares)   130,450      
Issuance of common stock under the employee stock purchase plan 3,419   3,419    
Share‑based compensation 89,524   89,524    
Foreign currency translation adjustments (56,218)     (56,218)  
Net loss (120,070)       (120,070)
Ending balance (in shares) at Sep. 30, 2022   121,340,085      
Ending balance at Sep. 30, 2022 659,763 $ 120 1,011,205 (64,084) (287,478)
Beginning balance (in shares) at Jun. 30, 2022   120,310,047      
Beginning balance at Jun. 30, 2022 693,946 $ 120 987,576 (37,574) (256,176)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   476,637      
Exercise of stock options 3,139   3,139    
Vesting of restricted stock units (in shares)   553,401      
Share‑based compensation 20,490   20,490    
Foreign currency translation adjustments (26,510)     (26,510)  
Net loss (31,302)       (31,302)
Ending balance (in shares) at Sep. 30, 2022   121,340,085      
Ending balance at Sep. 30, 2022 659,763 $ 120 1,011,205 (64,084) (287,478)
Beginning balance (in shares) at Dec. 31, 2022   123,170,172      
Beginning balance at Dec. 31, 2022 701,338 $ 123 1,049,875 (39,951) (308,709)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   778,589      
Exercise of stock options 5,640 $ 1 5,639    
Vesting of restricted stock units (in shares)   1,572,281      
Vesting of restricted stock units 2 $ 2      
Issuance of common stock under the employee stock purchase plan (in shares)   204,962      
Issuance of common stock under the employee stock purchase plan 3,131   3,131    
Share‑based compensation 78,082   78,082    
Foreign currency translation adjustments 3,900     3,900  
Net loss (92,676)       (92,676)
Ending balance (in shares) at Sep. 30, 2023   125,726,004      
Ending balance at Sep. 30, 2023 699,417 $ 126 1,136,727 (36,051) (401,385)
Beginning balance (in shares) at Jun. 30, 2023   124,890,541      
Beginning balance at Jun. 30, 2023 708,363 $ 125 1,105,703 (28,357) (369,108)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   370,564      
Exercise of stock options 2,675   2,675    
Vesting of restricted stock units (in shares)   464,899      
Vesting of restricted stock units 1 $ 1      
Share‑based compensation 28,349   28,349    
Foreign currency translation adjustments (7,694)     (7,694)  
Net loss (32,277)       (32,277)
Ending balance (in shares) at Sep. 30, 2023   125,726,004      
Ending balance at Sep. 30, 2023 $ 699,417 $ 126 $ 1,136,727 $ (36,051) $ (401,385)